Who founded Avenue Biosciences?

Avenue Biosciences was founded by Ville Paavilainen, Tero-Pekka Alastalo in 2023.

Who are Avenue Biosciences's investors?

Avenue Biosciences's investors include Balnord Sp. z o.o., Inventure, StartX, Inventure, Voima Ventures.

How much funding has Avenue Biosciences raised?

Avenue Biosciences has disclosed $11.4M raised across 2 rounds.

Where is Avenue Biosciences headquartered?

Avenue Biosciences is headquartered in Helsinki, FI.

Avenue Biosciences

Helsinki, FI · Founded 2023 · 23 employees on LinkedIn · 8 known investors

Find your way into Avenue Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Avenue Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Avenue Biosciences was founded in 2023 by Ville Paavilainen and Tero-Pekka Alastalo.

Ville PaavilainenCo-founder & Research Director

Tero-Pekka AlastaloFounder

AlastaloMD, PhD

RostiPhD, eMBA

Investors · 8

Balnord Sp. z o.o.listed by Balnord Sp. z o.o.Luxembourg · $550K – $3.3M

How we know: funding news · tech.eu · Not right? Tell us

Inventurelisted by InventureHelsinki

How we know: Inventure's portfolio page · Not right? Tell us

StartXlisted by StartXStanford · $10K – $1M

How we know: StartX's portfolio page · Not right? Tell us

InventurereportedHelsinki · $330K – $5.5M

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Voima VenturesreportedHelsinki · $216K – $3.2M

How we know: a partner's Signal profile · funding news · tech.eu · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

DimerentTesileadUniversity of Helsinki

Funding

SEC filings, press & company announcements

$11.4M disclosed across 2 rounds · 2026

$5.7MSeed ExtensionJan 2026 · 2 sources
Balnord (lead), Tesi (lead), Dimerent, Inventure, University of Helsinki, Voima Ventures
Source ↗
$5.7MraisedJan 2026 · 3 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Finnish startup Avenue Biosciences secures €4.8 million to help drugmakers manufacture proteins more reliably | EU-Startupseu-startups.com · Jan 2026

Avenue Biosciences Raises $5.7M in Seed Extension Fundingfinsmes.com · Jan 2026

Frequently asked questions

What does Avenue Biosciences do?: Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.
Who founded Avenue Biosciences?: Avenue Biosciences was founded by Ville Paavilainen, Tero-Pekka Alastalo in 2023.
Who are Avenue Biosciences's investors?: Avenue Biosciences's investors include Balnord Sp. z o.o., Inventure, StartX, Inventure, Voima Ventures.
How much funding has Avenue Biosciences raised?: Avenue Biosciences has disclosed $11.4M raised across 2 rounds.
Where is Avenue Biosciences headquartered?: Avenue Biosciences is headquartered in Helsinki, FI.